Global Alzheimer's Disease Drug Supply, Demand and Key Producers, 2024-2030

Page: 103

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Alzheimer's Disease Drug market size is expected to reach $ 4113.3 million by 2030, rising at a market growth of 1.4% CAGR during the forecast period (2024-2030).

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

This report studies the global Alzheimer's Disease Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Alzheimer's Disease Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Alzheimer's Disease Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Alzheimer's Disease Drug total production and demand, 2019-2030, (K Units)
Global Alzheimer's Disease Drug total production value, 2019-2030, (USD Million)
Global Alzheimer's Disease Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Alzheimer's Disease Drug consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Alzheimer's Disease Drug domestic production, consumption, key domestic manufacturers and share
Global Alzheimer's Disease Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Alzheimer's Disease Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Alzheimer's Disease Drug production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Alzheimer's Disease Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson and Lundbeck, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Alzheimer's Disease Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Alzheimer's Disease Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Alzheimer's Disease Drug Market, Segmentation by Type
Donepezil
Memantine
Rivastigmine
Others

Global Alzheimer's Disease Drug Market, Segmentation by Application
Early to Moderate Stages
Moderate to Severe Stages

Companies Profiled:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck

Key Questions Answered
1. How big is the global Alzheimer's Disease Drug market?
2. What is the demand of the global Alzheimer's Disease Drug market?
3. What is the year over year growth of the global Alzheimer's Disease Drug market?
4. What is the production and production value of the global Alzheimer's Disease Drug market?
5. Who are the key producers in the global Alzheimer's Disease Drug market?

Table of Contents

1 Supply Summary
    1.1 Alzheimer's Disease Drug Introduction
    1.2 World Alzheimer's Disease Drug Supply & Forecast
        1.2.1 World Alzheimer's Disease Drug Production Value (2019 & 2023 & 2030)
        1.2.2 World Alzheimer's Disease Drug Production (2019-2030)
        1.2.3 World Alzheimer's Disease Drug Pricing Trends (2019-2030)
    1.3 World Alzheimer's Disease Drug Production by Region (Based on Production Site)
        1.3.1 World Alzheimer's Disease Drug Production Value by Region (2019-2030)
        1.3.2 World Alzheimer's Disease Drug Production by Region (2019-2030)
        1.3.3 World Alzheimer's Disease Drug Average Price by Region (2019-2030)
        1.3.4 North America Alzheimer's Disease Drug Production (2019-2030)
        1.3.5 Europe Alzheimer's Disease Drug Production (2019-2030)
        1.3.6 Janpan Alzheimer's Disease Drug Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Alzheimer's Disease Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Alzheimer's Disease Drug Major Market Trends

2 Demand Summary
    2.1 World Alzheimer's Disease Drug Demand (2019-2030)
    2.2 World Alzheimer's Disease Drug Consumption by Region
        2.2.1 World Alzheimer's Disease Drug Consumption by Region (2019-2024)
        2.2.2 World Alzheimer's Disease Drug Consumption Forecast by Region (2025-2030)
    2.3 United States Alzheimer's Disease Drug Consumption (2019-2030)
    2.4 China Alzheimer's Disease Drug Consumption (2019-2030)
    2.5 Europe Alzheimer's Disease Drug Consumption (2019-2030)
    2.6 Japan Alzheimer's Disease Drug Consumption (2019-2030)
    2.7 South Korea Alzheimer's Disease Drug Consumption (2019-2030)
    2.8 ASEAN Alzheimer's Disease Drug Consumption (2019-2030)
    2.9 India Alzheimer's Disease Drug Consumption (2019-2030)

3 World Alzheimer's Disease Drug Manufacturers Competitive Analysis
    3.1 World Alzheimer's Disease Drug Production Value by Manufacturer (2019-2024)
    3.2 World Alzheimer's Disease Drug Production by Manufacturer (2019-2024)
    3.3 World Alzheimer's Disease Drug Average Price by Manufacturer (2019-2024)
    3.4 Alzheimer's Disease Drug Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Alzheimer's Disease Drug Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Alzheimer's Disease Drug in 2023
        3.5.3 Global Concentration Ratios (CR8) for Alzheimer's Disease Drug in 2023
    3.6 Alzheimer's Disease Drug Market: Overall Company Footprint Analysis
        3.6.1 Alzheimer's Disease Drug Market: Region Footprint
        3.6.2 Alzheimer's Disease Drug Market: Company Product Type Footprint
        3.6.3 Alzheimer's Disease Drug Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Alzheimer's Disease Drug Production Value Comparison
        4.1.1 United States VS China: Alzheimer's Disease Drug Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Alzheimer's Disease Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Alzheimer's Disease Drug Production Comparison
        4.2.1 United States VS China: Alzheimer's Disease Drug Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Alzheimer's Disease Drug Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Alzheimer's Disease Drug Consumption Comparison
        4.3.1 United States VS China: Alzheimer's Disease Drug Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Alzheimer's Disease Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Alzheimer's Disease Drug Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Alzheimer's Disease Drug Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Alzheimer's Disease Drug Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Alzheimer's Disease Drug Production (2019-2024)
    4.5 China Based Alzheimer's Disease Drug Manufacturers and Market Share
        4.5.1 China Based Alzheimer's Disease Drug Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Alzheimer's Disease Drug Production Value (2019-2024)
        4.5.3 China Based Manufacturers Alzheimer's Disease Drug Production (2019-2024)
    4.6 Rest of World Based Alzheimer's Disease Drug Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Alzheimer's Disease Drug Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Alzheimer's Disease Drug Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Alzheimer's Disease Drug Production (2019-2024)

5 Market Analysis by Type
    5.1 World Alzheimer's Disease Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Donepezil
        5.2.2 Memantine
        5.2.3 Rivastigmine
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Alzheimer's Disease Drug Production by Type (2019-2030)
        5.3.2 World Alzheimer's Disease Drug Production Value by Type (2019-2030)
        5.3.3 World Alzheimer's Disease Drug Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Alzheimer's Disease Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Early to Moderate Stages
        6.2.2 Moderate to Severe Stages
    6.3 Market Segment by Application
        6.3.1 World Alzheimer's Disease Drug Production by Application (2019-2030)
        6.3.2 World Alzheimer's Disease Drug Production Value by Application (2019-2030)
        6.3.3 World Alzheimer's Disease Drug Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Allergan
        7.1.1 Allergan Details
        7.1.2 Allergan Major Business
        7.1.3 Allergan Alzheimer's Disease Drug Product and Services
        7.1.4 Allergan Alzheimer's Disease Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Allergan Recent Developments/Updates
        7.1.6 Allergan Competitive Strengths & Weaknesses
    7.2 Eisai
        7.2.1 Eisai Details
        7.2.2 Eisai Major Business
        7.2.3 Eisai Alzheimer's Disease Drug Product and Services
        7.2.4 Eisai Alzheimer's Disease Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Eisai Recent Developments/Updates
        7.2.6 Eisai Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Alzheimer's Disease Drug Product and Services
        7.3.4 Novartis Alzheimer's Disease Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Daiichi Sankyo
        7.4.1 Daiichi Sankyo Details
        7.4.2 Daiichi Sankyo Major Business
        7.4.3 Daiichi Sankyo Alzheimer's Disease Drug Product and Services
        7.4.4 Daiichi Sankyo Alzheimer's Disease Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Daiichi Sankyo Recent Developments/Updates
        7.4.6 Daiichi Sankyo Competitive Strengths & Weaknesses
    7.5 Merz Pharma
        7.5.1 Merz Pharma Details
        7.5.2 Merz Pharma Major Business
        7.5.3 Merz Pharma Alzheimer's Disease Drug Product and Services
        7.5.4 Merz Pharma Alzheimer's Disease Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Merz Pharma Recent Developments/Updates
        7.5.6 Merz Pharma Competitive Strengths & Weaknesses
    7.6 Pfizer
        7.6.1 Pfizer Details
        7.6.2 Pfizer Major Business
        7.6.3 Pfizer Alzheimer's Disease Drug Product and Services
        7.6.4 Pfizer Alzheimer's Disease Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Pfizer Recent Developments/Updates
        7.6.6 Pfizer Competitive Strengths & Weaknesses
    7.7 Johnson & Johnson
        7.7.1 Johnson & Johnson Details
        7.7.2 Johnson & Johnson Major Business
        7.7.3 Johnson & Johnson Alzheimer's Disease Drug Product and Services
        7.7.4 Johnson & Johnson Alzheimer's Disease Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Johnson & Johnson Recent Developments/Updates
        7.7.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.8 Lundbeck
        7.8.1 Lundbeck Details
        7.8.2 Lundbeck Major Business
        7.8.3 Lundbeck Alzheimer's Disease Drug Product and Services
        7.8.4 Lundbeck Alzheimer's Disease Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Lundbeck Recent Developments/Updates
        7.8.6 Lundbeck Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Alzheimer's Disease Drug Industry Chain
    8.2 Alzheimer's Disease Drug Upstream Analysis
        8.2.1 Alzheimer's Disease Drug Core Raw Materials
        8.2.2 Main Manufacturers of Alzheimer's Disease Drug Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Alzheimer's Disease Drug Production Mode
    8.6 Alzheimer's Disease Drug Procurement Model
    8.7 Alzheimer's Disease Drug Industry Sales Model and Sales Channels
        8.7.1 Alzheimer's Disease Drug Sales Model
        8.7.2 Alzheimer's Disease Drug Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Alzheimer's Disease Drug Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Alzheimer's Disease Drug Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Alzheimer's Disease Drug Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Alzheimer's Disease Drug Production Value Market Share by Region (2019-2024)
    Table 5. World Alzheimer's Disease Drug Production Value Market Share by Region (2025-2030)
    Table 6. World Alzheimer's Disease Drug Production by Region (2019-2024) & (K Units)
    Table 7. World Alzheimer's Disease Drug Production by Region (2025-2030) & (K Units)
    Table 8. World Alzheimer's Disease Drug Production Market Share by Region (2019-2024)
    Table 9. World Alzheimer's Disease Drug Production Market Share by Region (2025-2030)
    Table 10. World Alzheimer's Disease Drug Average Price by Region (2019-2024) & (USD/Unit)
    Table 11. World Alzheimer's Disease Drug Average Price by Region (2025-2030) & (USD/Unit)
    Table 12. Alzheimer's Disease Drug Major Market Trends
    Table 13. World Alzheimer's Disease Drug Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Alzheimer's Disease Drug Consumption by Region (2019-2024) & (K Units)
    Table 15. World Alzheimer's Disease Drug Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Alzheimer's Disease Drug Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Alzheimer's Disease Drug Producers in 2023
    Table 18. World Alzheimer's Disease Drug Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Alzheimer's Disease Drug Producers in 2023
    Table 20. World Alzheimer's Disease Drug Average Price by Manufacturer (2019-2024) & (USD/Unit)
    Table 21. Global Alzheimer's Disease Drug Company Evaluation Quadrant
    Table 22. World Alzheimer's Disease Drug Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Alzheimer's Disease Drug Production Site of Key Manufacturer
    Table 24. Alzheimer's Disease Drug Market: Company Product Type Footprint
    Table 25. Alzheimer's Disease Drug Market: Company Product Application Footprint
    Table 26. Alzheimer's Disease Drug Competitive Factors
    Table 27. Alzheimer's Disease Drug New Entrant and Capacity Expansion Plans
    Table 28. Alzheimer's Disease Drug Mergers & Acquisitions Activity
    Table 29. United States VS China Alzheimer's Disease Drug Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Alzheimer's Disease Drug Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Alzheimer's Disease Drug Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Alzheimer's Disease Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Alzheimer's Disease Drug Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Alzheimer's Disease Drug Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Alzheimer's Disease Drug Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Alzheimer's Disease Drug Production Market Share (2019-2024)
    Table 37. China Based Alzheimer's Disease Drug Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Alzheimer's Disease Drug Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Alzheimer's Disease Drug Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Alzheimer's Disease Drug Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Alzheimer's Disease Drug Production Market Share (2019-2024)
    Table 42. Rest of World Based Alzheimer's Disease Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Alzheimer's Disease Drug Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Alzheimer's Disease Drug Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Alzheimer's Disease Drug Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Alzheimer's Disease Drug Production Market Share (2019-2024)
    Table 47. World Alzheimer's Disease Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Alzheimer's Disease Drug Production by Type (2019-2024) & (K Units)
    Table 49. World Alzheimer's Disease Drug Production by Type (2025-2030) & (K Units)
    Table 50. World Alzheimer's Disease Drug Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Alzheimer's Disease Drug Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Alzheimer's Disease Drug Average Price by Type (2019-2024) & (USD/Unit)
    Table 53. World Alzheimer's Disease Drug Average Price by Type (2025-2030) & (USD/Unit)
    Table 54. World Alzheimer's Disease Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Alzheimer's Disease Drug Production by Application (2019-2024) & (K Units)
    Table 56. World Alzheimer's Disease Drug Production by Application (2025-2030) & (K Units)
    Table 57. World Alzheimer's Disease Drug Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Alzheimer's Disease Drug Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Alzheimer's Disease Drug Average Price by Application (2019-2024) & (USD/Unit)
    Table 60. World Alzheimer's Disease Drug Average Price by Application (2025-2030) & (USD/Unit)
    Table 61. Allergan Basic Information, Manufacturing Base and Competitors
    Table 62. Allergan Major Business
    Table 63. Allergan Alzheimer's Disease Drug Product and Services
    Table 64. Allergan Alzheimer's Disease Drug Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Allergan Recent Developments/Updates
    Table 66. Allergan Competitive Strengths & Weaknesses
    Table 67. Eisai Basic Information, Manufacturing Base and Competitors
    Table 68. Eisai Major Business
    Table 69. Eisai Alzheimer's Disease Drug Product and Services
    Table 70. Eisai Alzheimer's Disease Drug Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Eisai Recent Developments/Updates
    Table 72. Eisai Competitive Strengths & Weaknesses
    Table 73. Novartis Basic Information, Manufacturing Base and Competitors
    Table 74. Novartis Major Business
    Table 75. Novartis Alzheimer's Disease Drug Product and Services
    Table 76. Novartis Alzheimer's Disease Drug Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Novartis Recent Developments/Updates
    Table 78. Novartis Competitive Strengths & Weaknesses
    Table 79. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
    Table 80. Daiichi Sankyo Major Business
    Table 81. Daiichi Sankyo Alzheimer's Disease Drug Product and Services
    Table 82. Daiichi Sankyo Alzheimer's Disease Drug Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Daiichi Sankyo Recent Developments/Updates
    Table 84. Daiichi Sankyo Competitive Strengths & Weaknesses
    Table 85. Merz Pharma Basic Information, Manufacturing Base and Competitors
    Table 86. Merz Pharma Major Business
    Table 87. Merz Pharma Alzheimer's Disease Drug Product and Services
    Table 88. Merz Pharma Alzheimer's Disease Drug Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Merz Pharma Recent Developments/Updates
    Table 90. Merz Pharma Competitive Strengths & Weaknesses
    Table 91. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 92. Pfizer Major Business
    Table 93. Pfizer Alzheimer's Disease Drug Product and Services
    Table 94. Pfizer Alzheimer's Disease Drug Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Pfizer Recent Developments/Updates
    Table 96. Pfizer Competitive Strengths & Weaknesses
    Table 97. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 98. Johnson & Johnson Major Business
    Table 99. Johnson & Johnson Alzheimer's Disease Drug Product and Services
    Table 100. Johnson & Johnson Alzheimer's Disease Drug Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Johnson & Johnson Recent Developments/Updates
    Table 102. Lundbeck Basic Information, Manufacturing Base and Competitors
    Table 103. Lundbeck Major Business
    Table 104. Lundbeck Alzheimer's Disease Drug Product and Services
    Table 105. Lundbeck Alzheimer's Disease Drug Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 106. Global Key Players of Alzheimer's Disease Drug Upstream (Raw Materials)
    Table 107. Alzheimer's Disease Drug Typical Customers
    Table 108. Alzheimer's Disease Drug Typical Distributors
List of Figure
    Figure 1. Alzheimer's Disease Drug Picture
    Figure 2. World Alzheimer's Disease Drug Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Alzheimer's Disease Drug Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Alzheimer's Disease Drug Production (2019-2030) & (K Units)
    Figure 5. World Alzheimer's Disease Drug Average Price (2019-2030) & (USD/Unit)
    Figure 6. World Alzheimer's Disease Drug Production Value Market Share by Region (2019-2030)
    Figure 7. World Alzheimer's Disease Drug Production Market Share by Region (2019-2030)
    Figure 8. North America Alzheimer's Disease Drug Production (2019-2030) & (K Units)
    Figure 9. Europe Alzheimer's Disease Drug Production (2019-2030) & (K Units)
    Figure 10. Janpan Alzheimer's Disease Drug Production (2019-2030) & (K Units)
    Figure 11. Alzheimer's Disease Drug Market Drivers
    Figure 12. Factors Affecting Demand
    Figure 13. World Alzheimer's Disease Drug Consumption (2019-2030) & (K Units)
    Figure 14. World Alzheimer's Disease Drug Consumption Market Share by Region (2019-2030)
    Figure 15. United States Alzheimer's Disease Drug Consumption (2019-2030) & (K Units)
    Figure 16. China Alzheimer's Disease Drug Consumption (2019-2030) & (K Units)
    Figure 17. Europe Alzheimer's Disease Drug Consumption (2019-2030) & (K Units)
    Figure 18. Japan Alzheimer's Disease Drug Consumption (2019-2030) & (K Units)
    Figure 19. South Korea Alzheimer's Disease Drug Consumption (2019-2030) & (K Units)
    Figure 20. ASEAN Alzheimer's Disease Drug Consumption (2019-2030) & (K Units)
    Figure 21. India Alzheimer's Disease Drug Consumption (2019-2030) & (K Units)
    Figure 22. Producer Shipments of Alzheimer's Disease Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 23. Global Four-firm Concentration Ratios (CR4) for Alzheimer's Disease Drug Markets in 2023
    Figure 24. Global Four-firm Concentration Ratios (CR8) for Alzheimer's Disease Drug Markets in 2023
    Figure 25. United States VS China: Alzheimer's Disease Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 26. United States VS China: Alzheimer's Disease Drug Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Alzheimer's Disease Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States Based Manufacturers Alzheimer's Disease Drug Production Market Share 2023
    Figure 29. China Based Manufacturers Alzheimer's Disease Drug Production Market Share 2023
    Figure 30. Rest of World Based Manufacturers Alzheimer's Disease Drug Production Market Share 2023
    Figure 31. World Alzheimer's Disease Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 32. World Alzheimer's Disease Drug Production Value Market Share by Type in 2023
    Figure 33. Donepezil
    Figure 34. Memantine
    Figure 35. Rivastigmine
    Figure 36. Others
    Figure 37. World Alzheimer's Disease Drug Production Market Share by Type (2019-2030)
    Figure 38. World Alzheimer's Disease Drug Production Value Market Share by Type (2019-2030)
    Figure 39. World Alzheimer's Disease Drug Average Price by Type (2019-2030) & (USD/Unit)
    Figure 40. World Alzheimer's Disease Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 41. World Alzheimer's Disease Drug Production Value Market Share by Application in 2023
    Figure 42. Early to Moderate Stages
    Figure 43. Moderate to Severe Stages
    Figure 44. World Alzheimer's Disease Drug Production Market Share by Application (2019-2030)
    Figure 45. World Alzheimer's Disease Drug Production Value Market Share by Application (2019-2030)
    Figure 46. World Alzheimer's Disease Drug Average Price by Application (2019-2030) & (USD/Unit)
    Figure 47. Alzheimer's Disease Drug Industry Chain
    Figure 48. Alzheimer's Disease Drug Procurement Model
    Figure 49. Alzheimer's Disease Drug Sales Model
    Figure 50. Alzheimer's Disease Drug Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck

Related Reports

Global Alzheimer's Disease Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Alzheimer's Disease Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Global Alzheimer's Disease Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Alzheimer's Disease Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Alzheimer's Disease Drug market size was valued at USD 3722.7 million in 2023 and is forecast to a readjusted size of USD 4113.3 million by 2030 with a CAGR of 1.4% during review period.

Product Tags

Alzheimer's Disease Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>